Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| IQVIA HOLDINGS INC.IQV · Entity 3058 | See Remarks | February 28, 2024 | March 01, 2024 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
IQVIA HOLDINGS INC.
Report date February 28, 2024 · Filed March 01, 2024
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 652 |
Ending reported balance
After 2024-02-28 transaction · row 5
5 source rows · reconciled sequenceRow 1 · 2024-02-28 · Exercise / conversion · Acquired 6,075 · Balance 6,727 Row 2 · 2024-02-28 · Exercise / conversion · Acquired 7,131 · Balance 13,858 Row 3 · 2024-02-28 · Sale · Disposed 6,425 · Balance 7,433 F1: The price reported in Column 4 is a weighted average price for shares sold in multiple transactions. The sale prices range from $249.48 to $250.47 per share. The reporting person has provided to the issuer, and undertakes to provide to the Commission staff or a security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (1) and (2) to this Form 4. Row 4 · 2024-02-28 · Sale · Disposed 2,182 · Balance 5,251 F2: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $250.59 to $251.07, inclusive. Row 5 · 2024-02-28 · Disposition to issuer · Disposed 4,599 · Balance 652 |
| Stock Appreciation RightSEC Table II · derivative / convertible security · Conversion / exercise price $78.21 · Expires 2027-02-02 | Direct | 0 |
Reported balance
After 2024-02-28 transaction · row 6
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 6 · 2024-02-28 · Exercise / conversion · Disposed 6,075 · Balance 0 |
| Stock Appreciation RightSEC Table II · derivative / convertible security · Conversion / exercise price $95.23 · Expires 2028-02-08 | Direct | 14,263 |
Reported balance
After 2024-02-28 transaction · row 7
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 7 · 2024-02-28 · Exercise / conversion · Disposed 7,131 · Balance 14,263 |
Filing footnotes · ownership attribution and instrument terms
F1: The price reported in Column 4 is a weighted average price for shares sold in multiple transactions. The sale prices range from $249.48 to $250.47 per share. The reporting person has provided to the issuer, and undertakes to provide to the Commission staff or a security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (1) and (2) to this Form 4.
F2: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $250.59 to $251.07, inclusive.
Past disclosures · reporting ended (1)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
IMS Health Holdings, Inc.
Report date October 03, 2016 · Filed October 03, 2016
Section 16 reporting ended · disclosed 2016-10-03. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 0 |
Ending reported balance
After 2016-10-03 transaction · row 4
4 source rows · reconciled sequenceRow 1 · 2016-09-30 · Grant · Acquired 31,908 · Balance 48,355 F1: Represents a grant of restricted stock received as an award under the Company's 2014 Incentive and Stock Award Plan, for no consideration, and exempt pursuant to Rule 16b-3 of the Securities Exchange Act of 1934, as amended. This grant will become vested as to one-third of the underlying shares on each of the first three anniversaries of the grant date. F2: On May 3, 2016, the issuer and Quintiles Transnational Holdings, Inc. ("Quintiles") entered into an Agreement and Plan of Merger pursuant to which on October 3, 2016 the issuer merged with and into Quintiles (the "merger"), the separate existence of the issuer ceased and Quintiles will continue as the surviving corporation, operating under the name Quintiles IMS Holdings, Inc. The restricted stock was assumed by Quintiles in the merger and replaced with restricted stock of 12,252 shares of Quintiles IMS Holdings, Inc. stock having a market value of $81.06 per share at the effective time of the merger. Row 2 · 2016-10-03 · Grant · Acquired 9,569 · Balance 57,924 F3: On February 10, 2015, the reporting person was granted 8,028 performance-based restricted stock units. The shares are earned based on the company's financial results over a three-year period (January 1, 2015 - December 31, 2017). In connection with the merger and based on the performance criteria achieved, 9,569 shares of issuer common stock were issued to the recipient. The performance-based restricted stock unit was assumed by Quintiles in the merger and replaced with a time-based restricted stock unit of 3,674 shares of Quintiles IMS Holdings, Inc. stock having a market value of $81.06 per share at the effective time of the merger. The shares will vest on December 31, 2017. Row 3 · 2016-10-03 · Grant · Acquired 11,942 · Balance 69,866 F4: On February 2, 2016, the reporting person was granted 8,673 performance-based restricted stock units. The shares are earned based on the company's financial results over a three-year period (January 1, 2016 - December 31, 2018). In connection with the merger and based on the performance criteria achieved, 11,942 shares of issuer common stock were issued to the recipient. The performance-based restricted stock unit was assumed by Quintiles in the merger and replaced with a time-based restricted stock unit of 4,585 shares of Quintiles IMS Holdings, Inc. stock having a market value of $81.06 per share at the effective time of the merger. The shares will vest on December 31, 2018. Row 4 · 2016-10-03 · Disposition to issuer · Disposed 69,866 · Balance 0 F5: Disposed of pursuant to merger agreement in exchange for 26,826 shares of Quintiles IMS Holdings, Inc. stock having a market value of $81.06 per share at the effective time of the merger. |
| Employee Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $10.00 · Expires 2020-03-15 | Direct | 0 |
Reported balance
After 2016-10-03 transaction · row 5
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 5 · 2016-10-03 · Disposition to issuer · Disposed 120,000 · Balance 0 F6: This option was assumed by Quintiles in the merger and replaced with an option to purchase 46,080 shares of Quintiles IMS Holdings, Inc. common stock at a price of $26.05 per share. |
| Employee Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $5.80 · Expires 2020-03-15 | Direct | 0 |
Reported balance
After 2016-10-03 transaction · row 6
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 6 · 2016-10-03 · Disposition to issuer · Disposed 60,000 · Balance 0 F7: This option was assumed by Quintiles in the merger and replaced with an option to purchase 23,040 shares of Quintiles IMS Holdings, Inc. common stock at a price of $15.11 per share. |
| Employee Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $3.20 · Expires 2020-03-15 | Direct | 0 |
Reported balance
After 2016-10-03 transaction · row 7
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 7 · 2016-10-03 · Disposition to issuer · Disposed 60,000 · Balance 0 F8: This option was assumed by Quintiles in the merger and replaced with an option to purchase 23,040 shares of Quintiles IMS Holdings, Inc. common stock at a price of $8.34 per share. |
| Stock Appreciation RightSEC Table II · derivative / convertible security · Conversion / exercise price $25.02 · Expires 2025-02-10 | Direct | 0 |
Reported balance
After 2016-10-03 transaction · row 8
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 8 · 2016-10-03 · Disposition to issuer · Disposed 5,393 · Balance 0 F9: This stock appreciation right was assumed by Quintiles in the merger and replaced with a stock appreciation right to purchase 2,071 shares of Quintiles IMS Holdings, Inc. common stock at a price of $65.16 per share. |
| Stock Appreciation RightSEC Table II · derivative / convertible security · Conversion / exercise price $25.02 · Expires 2025-02-10 | Direct | 0 |
Reported balance
After 2016-10-03 transaction · row 9
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 9 · 2016-10-03 · Disposition to issuer · Disposed 16,181 · Balance 0 F11: This stock appreciation right was assumed by Quintiles in the merger and replaced with a stock appreciation right to purchase 6,213 shares of Quintiles IMS Holdings, Inc. common stock at a price of $65.16 per share. F10: This stock appreciation right vests in three annual installments beginning on February 10, 2017. |
| Stock Appreciation RightSEC Table II · derivative / convertible security · Conversion / exercise price $23.00 · Expires 2026-02-02 | Direct | 0 |
Reported balance
After 2016-10-03 transaction · row 10
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 10 · 2016-10-03 · Disposition to issuer · Disposed 26,581 · Balance 0 F13: This stock appreciation right was assumed by Quintiles in the merger and replaced with a stock appreciation right to purchase 10,207 shares of Quintiles IMS Holdings, Inc. common stock at a price of $59.90 per share. F12: This stock appreciation right vests in four annual installments beginning on February 2, 2017. |
| Phantom StockSEC Table II · derivative / convertible security | Direct | 0 |
Reported balance
After 2016-10-03 transaction · row 11
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 11 · 2016-10-03 · Disposition to issuer · Disposed 48,349 · Balance 0 F14: Represents notional shares held under the Defined Contribution Executive Retirement Plan payable upon the Reporting Person's termination of employement. F15: All notional shares held under the Defined Contribution Executive Retirement Plan were assumed by Quintiles in the merger and replaced with a notional share to purchase 18,566 shares of Quintiles IMS Holdings, Inc. common stock having a market value of $81.06 per share at the effective time of the merger. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents a grant of restricted stock received as an award under the Company's 2014 Incentive and Stock Award Plan, for no consideration, and exempt pursuant to Rule 16b-3 of the Securities Exchange Act of 1934, as amended. This grant will become vested as to one-third of the underlying shares on each of the first three anniversaries of the grant date.
F2: On May 3, 2016, the issuer and Quintiles Transnational Holdings, Inc. ("Quintiles") entered into an Agreement and Plan of Merger pursuant to which on October 3, 2016 the issuer merged with and into Quintiles (the "merger"), the separate existence of the issuer ceased and Quintiles will continue as the surviving corporation, operating under the name Quintiles IMS Holdings, Inc. The restricted stock was assumed by Quintiles in the merger and replaced with restricted stock of 12,252 shares of Quintiles IMS Holdings, Inc. stock having a market value of $81.06 per share at the effective time of the merger.
F3: On February 10, 2015, the reporting person was granted 8,028 performance-based restricted stock units. The shares are earned based on the company's financial results over a three-year period (January 1, 2015 - December 31, 2017). In connection with the merger and based on the performance criteria achieved, 9,569 shares of issuer common stock were issued to the recipient. The performance-based restricted stock unit was assumed by Quintiles in the merger and replaced with a time-based restricted stock unit of 3,674 shares of Quintiles IMS Holdings, Inc. stock having a market value of $81.06 per share at the effective time of the merger. The shares will vest on December 31, 2017.
F4: On February 2, 2016, the reporting person was granted 8,673 performance-based restricted stock units. The shares are earned based on the company's financial results over a three-year period (January 1, 2016 - December 31, 2018). In connection with the merger and based on the performance criteria achieved, 11,942 shares of issuer common stock were issued to the recipient. The performance-based restricted stock unit was assumed by Quintiles in the merger and replaced with a time-based restricted stock unit of 4,585 shares of Quintiles IMS Holdings, Inc. stock having a market value of $81.06 per share at the effective time of the merger. The shares will vest on December 31, 2018.
F5: Disposed of pursuant to merger agreement in exchange for 26,826 shares of Quintiles IMS Holdings, Inc. stock having a market value of $81.06 per share at the effective time of the merger.
F6: This option was assumed by Quintiles in the merger and replaced with an option to purchase 46,080 shares of Quintiles IMS Holdings, Inc. common stock at a price of $26.05 per share.
F7: This option was assumed by Quintiles in the merger and replaced with an option to purchase 23,040 shares of Quintiles IMS Holdings, Inc. common stock at a price of $15.11 per share.
F8: This option was assumed by Quintiles in the merger and replaced with an option to purchase 23,040 shares of Quintiles IMS Holdings, Inc. common stock at a price of $8.34 per share.
F9: This stock appreciation right was assumed by Quintiles in the merger and replaced with a stock appreciation right to purchase 2,071 shares of Quintiles IMS Holdings, Inc. common stock at a price of $65.16 per share.
F10: This stock appreciation right vests in three annual installments beginning on February 10, 2017.
F11: This stock appreciation right was assumed by Quintiles in the merger and replaced with a stock appreciation right to purchase 6,213 shares of Quintiles IMS Holdings, Inc. common stock at a price of $65.16 per share.
F12: This stock appreciation right vests in four annual installments beginning on February 2, 2017.
F13: This stock appreciation right was assumed by Quintiles in the merger and replaced with a stock appreciation right to purchase 10,207 shares of Quintiles IMS Holdings, Inc. common stock at a price of $59.90 per share.
F14: Represents notional shares held under the Defined Contribution Executive Retirement Plan payable upon the Reporting Person's termination of employement.
F15: All notional shares held under the Defined Contribution Executive Retirement Plan were assumed by Quintiles in the merger and replaced with a notional share to purchase 18,566 shares of Quintiles IMS Holdings, Inc. common stock having a market value of $81.06 per share at the effective time of the merger.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| September 30, 2019 Filed Oct 2, 2019 21:04 UTC | IQVIA HOLDINGS INC. IQV · Entity 3058 | Tax withholdingCommon Stock | 1,893 | $149.38 | $282,776.34 |
DisclosureSEC source: 0001478242-19-000040 · edgar.xml · nonDerivative · entry 1 Knightly Kevin C · CIK 0001350000 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,191 Read SEC document |
| August 01, 2019 Filed Aug 5, 2019 21:05 UTC | IQVIA HOLDINGS INC. IQV · Entity 3058 | SaleCommon Stock | 4,278 | $158.50 | $678,063.00 |
DisclosureSEC source: 0001478242-19-000039 · edgar.xml · nonDerivative · entry 1 Knightly Kevin C · CIK 0001350000 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,084 Read SEC document |
| July 29, 2019 Filed Jul 31, 2019 21:00 UTC | IQVIA HOLDINGS INC. IQV · Entity 3058 | SaleCommon Stock | 6,945 | $158.53 | $1,100,990.85 |
DisclosureSEC source: 0001478242-19-000037 · edgar.xml · nonDerivative · entry 1 Knightly Kevin C · CIK 0001350000 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,362 F1 · price: The price reported in Column 4 is a weighted average price for shares sold in multiple transactions. The sale prices range from $158.45 to $158.55 per share. The reporting person has provided to the issuer, and undertakes to provide to the Commission staff or a security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| May 03, 2019 Filed May 7, 2019 21:16 UTC | IQVIA HOLDINGS INC. IQV · Entity 3058 | OtherEmployee Stock Option (Right to Buy) · Derivative | 46,080 | $0.00 Strike: $26.05 | $0.00 |
DisclosureSEC source: 0001478242-19-000025 · edgar.xml · derivative · entry 3 Knightly Kevin C · CIK 0001350000 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 46,080 shares Expires 2020-03-15 Read SEC document |
| May 03, 2019 Filed May 7, 2019 21:16 UTC | IQVIA HOLDINGS INC. IQV · Entity 3058 | SaleCommon Stock | 46,080 | $138.06 | $6,361,804.80 |
DisclosureSEC source: 0001478242-19-000025 · edgar.xml · nonDerivative · entry 2 Knightly Kevin C · CIK 0001350000 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,307 F1 · price: The price reported in Column 4 is a weighted average price for shares sold in multiple transactions. The sale prices range from $138.00 to $138.21 per share. The reporting person has provided to the issuer, and undertakes to provide to the Commission staff or a security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| May 03, 2019 Filed May 7, 2019 21:16 UTC | IQVIA HOLDINGS INC. IQV · Entity 3058 | OtherCommon Stock | 46,080 | $26.05 | $1,200,384.00 |
DisclosureSEC source: 0001478242-19-000025 · edgar.xml · nonDerivative · entry 1 Knightly Kevin C · CIK 0001350000 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 61,387 Read SEC document |
| February 13, 2019 Filed Feb 15, 2019 22:10 UTC | IQVIA HOLDINGS INC. IQV · Entity 3058 | GrantStock Appreciation Right · Derivative | 18,436 | $0.00 Strike: $131.82 | $0.00 |
DisclosureSEC source: 0001478242-19-000011 · edgar.xml · derivative · entry 1 Knightly Kevin C · CIK 0001350000 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,436 Underlying: Common Stock · 18,436 shares Expires 2029-02-13 F1 · derivative.exercise_date: This stock appreciation right vests in three annual installments beginning on 02/13/2020. Read SEC document |
| December 31, 2018 Filed Jan 3, 2019 22:16 UTC | IQVIA HOLDINGS INC. IQV · Entity 3058 | Tax withholdingCommon Stock | 2,124 | $116.17 | $246,745.08 |
DisclosureSEC source: 0001478242-19-000002 · edgar.xml · nonDerivative · entry 1 Knightly Kevin C · CIK 0001350000 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,307 Read SEC document |
| September 30, 2018 Filed Oct 2, 2018 21:28 UTC | IQVIA HOLDINGS INC. IQV · Entity 3058 | Tax withholdingCommon Stock | 1,892 | $129.74 | $245,468.08 |
DisclosureSEC source: 0001478242-18-000056 · edgar.xml · nonDerivative · entry 1 Knightly Kevin C · CIK 0001350000 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,431 Read SEC document |
| September 07, 2018 Filed Sep 11, 2018 20:25 UTC | IQVIA HOLDINGS INC. IQV · Entity 3058 | OtherEmployee Stock Option (Right to Buy) · Derivative | 9,216 | $0.00 Strike: $15.11 | $0.00 |
DisclosureSEC source: 0001478242-18-000053 · edgar.xml · derivative · entry 3 Knightly Kevin C · CIK 0001350000 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 9,216 shares Expires 2020-03-15 Read SEC document |
| September 07, 2018 Filed Sep 11, 2018 20:25 UTC | IQVIA HOLDINGS INC. IQV · Entity 3058 | SaleCommon Stock | 9,216 | $126.46 | $1,165,455.36 |
DisclosureSEC source: 0001478242-18-000053 · edgar.xml · nonDerivative · entry 2 Knightly Kevin C · CIK 0001350000 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,323 F1 · price: The price reported in Column 4 is a weighted average price for shares sold in multiple transactions. The sale prices range from $126.40 to $126.65 per share. The reporting person has provided to the issuer, and undertakes to provide to the Commission staff or a security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| September 07, 2018 Filed Sep 11, 2018 20:25 UTC | IQVIA HOLDINGS INC. IQV · Entity 3058 | OtherCommon Stock | 9,216 | $15.11 | $139,253.76 |
DisclosureSEC source: 0001478242-18-000053 · edgar.xml · nonDerivative · entry 1 Knightly Kevin C · CIK 0001350000 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,539 Read SEC document |
| February 12, 2018 Filed Feb 14, 2018 23:45 UTC | IQVIA HOLDINGS INC. IQV · Entity 3058 | Tax withholdingCommon Stock | 1,232 | $98.63 | $121,512.16 |
DisclosureSEC source: 0001478242-18-000011 · edgar.xml · nonDerivative · entry 1 Knightly Kevin C · CIK 0001350000 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,323 Read SEC document |
| February 08, 2018 Filed Feb 13, 2018 02:39 UTC | IQVIA HOLDINGS INC. IQV · Entity 3058 | GrantStock Appreciation Right · Derivative | 21,394 | $0.00 Strike: $95.23 | $0.00 |
DisclosureSEC source: 0001478242-18-000008 · edgar.xml · derivative · entry 1 Knightly Kevin C · CIK 0001350000 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,394 Underlying: Common Stock · 21,394 shares Expires 2028-02-08 F1 · derivative.exercise_date: This stock appreciation right vests in three annual installments beginning on 02/08/2019. Read SEC document |
| December 31, 2017 Filed Jan 3, 2018 21:36 UTC | IQVIA HOLDINGS INC. IQV · Entity 3058 | Tax withholdingCommon Stock | 1,798 | $97.90 | $176,024.20 |
DisclosureSEC source: 0001478242-18-000001 · edgar.xml · nonDerivative · entry 1 Knightly Kevin C · CIK 0001350000 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,555 Read SEC document |
| September 30, 2017 Filed Oct 3, 2017 20:20 UTC | IQVIA HOLDINGS INC. Q · Entity 3058 | Tax withholdingCommon Stock | 1,998 | $95.07 | $189,949.86 |
DisclosureSEC source: 0001478242-17-000062 · edgar.xml · nonDerivative · entry 1 Knightly Kevin C · CIK 0001350000 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,353 Read SEC document |
| August 25, 2017 Filed Aug 28, 2017 20:45 UTC | IQVIA HOLDINGS INC. Q · Entity 3058 | OtherEmployee Stock Option (Right to Buy) · Derivative | 3,040 | $0.00 Strike: $8.34 | $0.00 |
DisclosureSEC source: 0001478242-17-000055 · edgar.xml · derivative · entry 6 Knightly Kevin C · CIK 0001350000 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 3,040 shares Expires 2020-03-15 Read SEC document |
| August 25, 2017 Filed Aug 28, 2017 20:45 UTC | IQVIA HOLDINGS INC. Q · Entity 3058 | OtherEmployee Stock Option (Right to Buy) · Derivative | 13,824 | $0.00 Strike: $15.11 | $0.00 |
DisclosureSEC source: 0001478242-17-000055 · edgar.xml · derivative · entry 5 Knightly Kevin C · CIK 0001350000 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 13,824 shares Expires 2020-03-15 Read SEC document |
| August 25, 2017 Filed Aug 28, 2017 20:45 UTC | IQVIA HOLDINGS INC. Q · Entity 3058 | SaleCommon Stock | 2,475 | $99.58 | $246,460.50 |
DisclosureSEC source: 0001478242-17-000055 · edgar.xml · nonDerivative · entry 4 Knightly Kevin C · CIK 0001350000 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,351 Read SEC document |
| August 25, 2017 Filed Aug 28, 2017 20:45 UTC | IQVIA HOLDINGS INC. Q · Entity 3058 | SaleCommon Stock | 16,864 | $99.50 | $1,677,968.00 |
DisclosureSEC source: 0001478242-17-000055 · edgar.xml · nonDerivative · entry 3 Knightly Kevin C · CIK 0001350000 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,826 F1 · price: The price reported in Column 4 is a weighted average price for shares sold in multiple transactions. The sale prices range from $99.30 to $99.62 per share. The reporting person has provided to the issuer, and undertakes to provide to the Commission staff or a security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| August 25, 2017 Filed Aug 28, 2017 20:45 UTC | IQVIA HOLDINGS INC. Q · Entity 3058 | OtherCommon Stock | 3,040 | $8.34 | $25,353.60 |
DisclosureSEC source: 0001478242-17-000055 · edgar.xml · nonDerivative · entry 2 Knightly Kevin C · CIK 0001350000 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 43,690 Read SEC document |
| August 25, 2017 Filed Aug 28, 2017 20:45 UTC | IQVIA HOLDINGS INC. Q · Entity 3058 | OtherCommon Stock | 13,824 | $15.11 | $208,880.64 |
DisclosureSEC source: 0001478242-17-000055 · edgar.xml · nonDerivative · entry 1 Knightly Kevin C · CIK 0001350000 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,650 Read SEC document |
| August 09, 2017 Filed Aug 11, 2017 20:16 UTC | IQVIA HOLDINGS INC. Q · Entity 3058 | OtherEmployee Stock Option (Right to Buy) · Derivative | 20,000 | $0.00 Strike: $8.34 | $0.00 |
DisclosureSEC source: 0001478242-17-000052 · edgar.xml · derivative · entry 3 Knightly Kevin C · CIK 0001350000 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,040 Underlying: Common Stock · 20,000 shares Expires 2020-03-15 Read SEC document |
| August 09, 2017 Filed Aug 11, 2017 20:16 UTC | IQVIA HOLDINGS INC. Q · Entity 3058 | SaleCommon Stock | 20,000 | $90.28 | $1,805,600.00 |
DisclosureSEC source: 0001478242-17-000052 · edgar.xml · nonDerivative · entry 2 Knightly Kevin C · CIK 0001350000 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,826 F1 · price: The price reported in Column 4 is a weighted average price for shares sold in multiple transactions. The sale prices range from $90.25 to $90.39 per share. The reporting person has provided to the issuer, and undertakes to provide to the Commission staff or a security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| August 09, 2017 Filed Aug 11, 2017 20:16 UTC | IQVIA HOLDINGS INC. Q · Entity 3058 | OtherCommon Stock | 20,000 | $8.34 | $166,800.00 |
DisclosureSEC source: 0001478242-17-000052 · edgar.xml · nonDerivative · entry 1 Knightly Kevin C · CIK 0001350000 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 46,826 Read SEC document |
| February 02, 2017 Filed Feb 6, 2017 22:05 UTC | IQVIA HOLDINGS INC. Q · Entity 3058 | GrantStock Appreciation Right · Derivative | 18,224 | $0.00 Strike: $78.21 | $0.00 |
DisclosureSEC source: 0001478242-17-000003 · edgar.xml · derivative · entry 1 Knightly Kevin C · CIK 0001350000 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,224 Underlying: Common Stock · 18,224 shares Expires 2027-02-02 F1 · derivative.exercise_date: This stock appreciation right vests in three annual installments beginning on 02/02/2018. Read SEC document |
| October 03, 2016 Filed Oct 3, 2016 18:52 UTC | IMS Health Holdings, Inc. IMS · Entity 174539 | Disposition to issuerPhantom Stock · Derivative | 48,349 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001595262-16-000060 · edgar.xml · derivative · entry 11 Knightly Kevin C · CIK 0001350000 · SVP, Information Offerings 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 48,349 shares Expires not disclosed F14 · derivative.exercise_price: Represents notional shares held under the Defined Contribution Executive Retirement Plan payable upon the Reporting Person's termination of employement. F15 · price: All notional shares held under the Defined Contribution Executive Retirement Plan were assumed by Quintiles in the merger and replaced with a notional share to purchase 18,566 shares of Quintiles IMS Holdings, Inc. common stock having a market value of $81.06 per share at the effective time of the merger. F14 · derivative.exercise_date: Represents notional shares held under the Defined Contribution Executive Retirement Plan payable upon the Reporting Person's termination of employement. F14 · derivative.expiration_date: Represents notional shares held under the Defined Contribution Executive Retirement Plan payable upon the Reporting Person's termination of employement. Read SEC document |
| October 03, 2016 Filed Oct 3, 2016 18:52 UTC | IMS Health Holdings, Inc. IMS · Entity 174539 | Disposition to issuerStock Appreciation Right · Derivative | 26,581 | Not disclosed Strike: $23.00 | Not disclosed |
DisclosureSEC source: 0001595262-16-000060 · edgar.xml · derivative · entry 10 Knightly Kevin C · CIK 0001350000 · SVP, Information Offerings 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 26,581 shares Expires 2026-02-02 F13 · price: This stock appreciation right was assumed by Quintiles in the merger and replaced with a stock appreciation right to purchase 10,207 shares of Quintiles IMS Holdings, Inc. common stock at a price of $59.90 per share. F12 · derivative.exercise_date: This stock appreciation right vests in four annual installments beginning on February 2, 2017. Read SEC document |
| October 03, 2016 Filed Oct 3, 2016 18:52 UTC | IMS Health Holdings, Inc. IMS · Entity 174539 | Disposition to issuerStock Appreciation Right · Derivative | 16,181 | Not disclosed Strike: $25.02 | Not disclosed |
DisclosureSEC source: 0001595262-16-000060 · edgar.xml · derivative · entry 9 Knightly Kevin C · CIK 0001350000 · SVP, Information Offerings 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 16,181 shares Expires 2025-02-10 F11 · price: This stock appreciation right was assumed by Quintiles in the merger and replaced with a stock appreciation right to purchase 6,213 shares of Quintiles IMS Holdings, Inc. common stock at a price of $65.16 per share. F10 · derivative.exercise_date: This stock appreciation right vests in three annual installments beginning on February 10, 2017. Read SEC document |
| October 03, 2016 Filed Oct 3, 2016 18:52 UTC | IMS Health Holdings, Inc. IMS · Entity 174539 | Disposition to issuerStock Appreciation Right · Derivative | 5,393 | Not disclosed Strike: $25.02 | Not disclosed |
DisclosureSEC source: 0001595262-16-000060 · edgar.xml · derivative · entry 8 Knightly Kevin C · CIK 0001350000 · SVP, Information Offerings 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 5,393 shares Expires 2025-02-10 F9 · price: This stock appreciation right was assumed by Quintiles in the merger and replaced with a stock appreciation right to purchase 2,071 shares of Quintiles IMS Holdings, Inc. common stock at a price of $65.16 per share. Read SEC document |
| October 03, 2016 Filed Oct 3, 2016 18:52 UTC | IMS Health Holdings, Inc. IMS · Entity 174539 | Disposition to issuerEmployee Stock Option (right to buy) · Derivative | 60,000 | Not disclosed Strike: $3.20 | Not disclosed |
DisclosureSEC source: 0001595262-16-000060 · edgar.xml · derivative · entry 7 Knightly Kevin C · CIK 0001350000 · SVP, Information Offerings 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 60,000 shares Expires 2020-03-15 F8 · price: This option was assumed by Quintiles in the merger and replaced with an option to purchase 23,040 shares of Quintiles IMS Holdings, Inc. common stock at a price of $8.34 per share. Read SEC document |
| October 03, 2016 Filed Oct 3, 2016 18:52 UTC | IMS Health Holdings, Inc. IMS · Entity 174539 | Disposition to issuerEmployee Stock Option (right to buy) · Derivative | 60,000 | Not disclosed Strike: $5.80 | Not disclosed |
DisclosureSEC source: 0001595262-16-000060 · edgar.xml · derivative · entry 6 Knightly Kevin C · CIK 0001350000 · SVP, Information Offerings 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 60,000 shares Expires 2020-03-15 F7 · price: This option was assumed by Quintiles in the merger and replaced with an option to purchase 23,040 shares of Quintiles IMS Holdings, Inc. common stock at a price of $15.11 per share. Read SEC document |
| October 03, 2016 Filed Oct 3, 2016 18:52 UTC | IMS Health Holdings, Inc. IMS · Entity 174539 | Disposition to issuerEmployee Stock Option (right to buy) · Derivative | 120,000 | Not disclosed Strike: $10.00 | Not disclosed |
DisclosureSEC source: 0001595262-16-000060 · edgar.xml · derivative · entry 5 Knightly Kevin C · CIK 0001350000 · SVP, Information Offerings 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 120,000 shares Expires 2020-03-15 F6 · price: This option was assumed by Quintiles in the merger and replaced with an option to purchase 46,080 shares of Quintiles IMS Holdings, Inc. common stock at a price of $26.05 per share. Read SEC document |
| October 03, 2016 Filed Oct 3, 2016 18:52 UTC | IMS Health Holdings, Inc. IMS · Entity 174539 | Disposition to issuerCommon Stock | 69,866 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001595262-16-000060 · edgar.xml · nonDerivative · entry 4 Knightly Kevin C · CIK 0001350000 · SVP, Information Offerings 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F5 · price: Disposed of pursuant to merger agreement in exchange for 26,826 shares of Quintiles IMS Holdings, Inc. stock having a market value of $81.06 per share at the effective time of the merger. Read SEC document |
| October 03, 2016 Filed Oct 3, 2016 18:52 UTC | IMS Health Holdings, Inc. IMS · Entity 174539 | GrantCommon Stock | 11,942 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001595262-16-000060 · edgar.xml · nonDerivative · entry 3 Knightly Kevin C · CIK 0001350000 · SVP, Information Offerings 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 69,866 F4 · price: On February 2, 2016, the reporting person was granted 8,673 performance-based restricted stock units. The shares are earned based on the company's financial results over a three-year period (January 1, 2016 - December 31, 2018). In connection with the merger and based on the performance criteria achieved, 11,942 shares of issuer common stock were issued to the recipient. The performance-based restricted stock unit was assumed by Quintiles in the merger and replaced with a time-based restricted stock unit of 4,585 shares of Quintiles IMS Holdings, Inc. stock having a market value of $81.06 per share at the effective time of the merger. The shares will vest on December 31, 2018. Read SEC document |
| October 03, 2016 Filed Oct 3, 2016 18:52 UTC | IMS Health Holdings, Inc. IMS · Entity 174539 | GrantCommon Stock | 9,569 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001595262-16-000060 · edgar.xml · nonDerivative · entry 2 Knightly Kevin C · CIK 0001350000 · SVP, Information Offerings 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 57,924 F3 · price: On February 10, 2015, the reporting person was granted 8,028 performance-based restricted stock units. The shares are earned based on the company's financial results over a three-year period (January 1, 2015 - December 31, 2017). In connection with the merger and based on the performance criteria achieved, 9,569 shares of issuer common stock were issued to the recipient. The performance-based restricted stock unit was assumed by Quintiles in the merger and replaced with a time-based restricted stock unit of 3,674 shares of Quintiles IMS Holdings, Inc. stock having a market value of $81.06 per share at the effective time of the merger. The shares will vest on December 31, 2017. Read SEC document |
| October 03, 2016 Filed Oct 5, 2016 20:41 UTC | IQVIA HOLDINGS INC. Q · Entity 3058 | GrantPhantom Stock · Derivative | 18,566 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-16-145004 · doc4.xml · derivative · entry 7 Knightly Kevin C · CIK 0001350000 · Pres Info & Tech Solutions 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,566 Underlying: Common Stock · 18,566 shares Expires not disclosed F10 · derivative.exercise_price: Represents notional shares held under the Quintiles IMS Holdings, Inc. Defined Contribution Executive Retirement Plan payable upon the reporting person's termination of employment. F1 · price: On May 3, 2016, Quintiles Transnational Holdings Inc. ("Quintiles") and IMS Health Holdings, Inc. ("IMS Health") entered into an Agreement and Plan of Merger pursuant to which, on October 3, 2016, IMS Health merged with and into Quintiles (the "Merger"), the separate existence of IMS Health ceased and Quintiles continued as the surviving corporation, operating under the name Quintiles IMS Holdings, Inc. ("Quintiles IMS Holdings"). The exchange ratio in the Merger was 0.3840 shares of Quintiles common stock for each share of IMS Health common stock. On the effective date of the Merger, the market value of Quintiles' common stock was $81.06 per share, and the market value of IMS Health's common stock was $31.34 per share. F11 · price: Received in the Merger in exchange for a notional share to purchase 48,349 shares of IMS Health common stock. F10 · derivative.exercise_date: Represents notional shares held under the Quintiles IMS Holdings, Inc. Defined Contribution Executive Retirement Plan payable upon the reporting person's termination of employment. F10 · derivative.expiration_date: Represents notional shares held under the Quintiles IMS Holdings, Inc. Defined Contribution Executive Retirement Plan payable upon the reporting person's termination of employment. Read SEC document |
| October 03, 2016 Filed Oct 5, 2016 20:41 UTC | IQVIA HOLDINGS INC. Q · Entity 3058 | GrantStock Appreciation Right · Derivative | 10,207 | Not disclosed Strike: $59.90 | Not disclosed |
DisclosureSEC source: 0001209191-16-145004 · doc4.xml · derivative · entry 6 Knightly Kevin C · CIK 0001350000 · Pres Info & Tech Solutions 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,207 Underlying: Common Stock · 10,207 shares Expires 2026-02-02 F9 · price: Received in the Merger in exchange for a stock appreciation right to acquire 26,581 shares of IMS Health common stock for $23.00 per share. F8 · derivative.exercise_date: This stock appreciation right vests in four annual installments beginning on February 2, 2017. Read SEC document |
| October 03, 2016 Filed Oct 5, 2016 20:41 UTC | IQVIA HOLDINGS INC. Q · Entity 3058 | GrantStock Appreciation Right · Derivative | 8,284 | Not disclosed Strike: $65.16 | Not disclosed |
DisclosureSEC source: 0001209191-16-145004 · doc4.xml · derivative · entry 5 Knightly Kevin C · CIK 0001350000 · Pres Info & Tech Solutions 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,284 Underlying: Common Stock · 8,284 shares Expires 2025-02-10 F7 · price: Received in the Merger in exchange for a stock appreciation right to acquire 21,574 shares of IMS Health common stock for $25.02 per share. F6 · derivative.exercise_date: This stock appreciation right vests in four annual installments, with the first installment having vested on February 10, 2016 and the remaining three installments vesting on February 10, 2017, 2018 and 2019. Read SEC document |
| October 03, 2016 Filed Oct 5, 2016 20:41 UTC | IQVIA HOLDINGS INC. Q · Entity 3058 | GrantEmployee Stock Option (Right to Buy) · Derivative | 23,040 | Not disclosed Strike: $8.34 | Not disclosed |
DisclosureSEC source: 0001209191-16-145004 · doc4.xml · derivative · entry 4 Knightly Kevin C · CIK 0001350000 · Pres Info & Tech Solutions 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,040 Underlying: Common Stock · 23,040 shares Expires 2020-03-15 F5 · price: Received in the Merger in exchange for a stock option to acquire 60,000 shares of IMS Health common stock for $3.20 per share. Read SEC document |
| October 03, 2016 Filed Oct 5, 2016 20:41 UTC | IQVIA HOLDINGS INC. Q · Entity 3058 | GrantEmployee Stock Option (Right to Buy) · Derivative | 23,040 | Not disclosed Strike: $15.11 | Not disclosed |
DisclosureSEC source: 0001209191-16-145004 · doc4.xml · derivative · entry 3 Knightly Kevin C · CIK 0001350000 · Pres Info & Tech Solutions 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,040 Underlying: Common Stock · 23,040 shares Expires 2020-03-15 F4 · price: Received in the Merger in exchange for a stock option to acquire 60,000 shares of IMS Health common stock for $5.80 per share. Read SEC document |
| October 03, 2016 Filed Oct 5, 2016 20:41 UTC | IQVIA HOLDINGS INC. Q · Entity 3058 | GrantEmployee Stock Option (Right to Buy) · Derivative | 46,080 | Not disclosed Strike: $26.05 | Not disclosed |
DisclosureSEC source: 0001209191-16-145004 · doc4.xml · derivative · entry 2 Knightly Kevin C · CIK 0001350000 · Pres Info & Tech Solutions 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 46,080 Underlying: Common Stock · 46,080 shares Expires 2020-03-15 F3 · price: Received in the Merger in exchange for a stock option to acquire 120,000 shares of IMS Health common stock for $10.00 per share. Read SEC document |
| October 03, 2016 Filed Oct 5, 2016 20:41 UTC | IQVIA HOLDINGS INC. Q · Entity 3058 | GrantCommon Stock | 26,826 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-16-145004 · doc4.xml · nonDerivative · entry 1 Knightly Kevin C · CIK 0001350000 · Pres Info & Tech Solutions 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,826 F1 · price: On May 3, 2016, Quintiles Transnational Holdings Inc. ("Quintiles") and IMS Health Holdings, Inc. ("IMS Health") entered into an Agreement and Plan of Merger pursuant to which, on October 3, 2016, IMS Health merged with and into Quintiles (the "Merger"), the separate existence of IMS Health ceased and Quintiles continued as the surviving corporation, operating under the name Quintiles IMS Holdings, Inc. ("Quintiles IMS Holdings"). The exchange ratio in the Merger was 0.3840 shares of Quintiles common stock for each share of IMS Health common stock. On the effective date of the Merger, the market value of Quintiles' common stock was $81.06 per share, and the market value of IMS Health's common stock was $31.34 per share. F2 · price: Received in exchange for 69,866 shares of IMS Health common stock, restricted stock and restricted stock units in connection with the Merger. Read SEC document |
| September 30, 2016 Filed Oct 3, 2016 18:52 UTC | IMS Health Holdings, Inc. IMS · Entity 174539 | GrantCommon Stock | 31,908 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001595262-16-000060 · edgar.xml · nonDerivative · entry 1 Knightly Kevin C · CIK 0001350000 · SVP, Information Offerings 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 48,355 F1 · price: Represents a grant of restricted stock received as an award under the Company's 2014 Incentive and Stock Award Plan, for no consideration, and exempt pursuant to Rule 16b-3 of the Securities Exchange Act of 1934, as amended. This grant will become vested as to one-third of the underlying shares on each of the first three anniversaries of the grant date. F2 · price: On May 3, 2016, the issuer and Quintiles Transnational Holdings, Inc. ("Quintiles") entered into an Agreement and Plan of Merger pursuant to which on October 3, 2016 the issuer merged with and into Quintiles (the "merger"), the separate existence of the issuer ceased and Quintiles will continue as the surviving corporation, operating under the name Quintiles IMS Holdings, Inc. The restricted stock was assumed by Quintiles in the merger and replaced with restricted stock of 12,252 shares of Quintiles IMS Holdings, Inc. stock having a market value of $81.06 per share at the effective time of the merger. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.